ARTICLE | Company News
Brickell Biotech, Signum Dermatologix Inc. deal
February 18, 2013 8:00 AM UTC
Last December, Brickell terminated an April 2012 deal with Signum (formerly Argyle Therapeutics Inc.) granting Brickell exclusive, worldwide rights to develop and commercialize SIG990 for dermatolog...